← back to search

Douglas Fleming

The University of Texas at Austin · US
Area of research
Epidemiology · General Health Professions
Research interest
Research focused on Vaccination and Phase (matter), with related work in Carcinoid syndrome, Case fatality rate, Medical prescription. Notable publications include 'The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy', 'Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial', and 'Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide'.
h-index
citations
543
works
4
NIH funding
primary concept
email

Recent publications

Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial
Endocrine Related Cancer 2018cited by 135position: middledoi
Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012
PLoS ONE 2015cited by 25position: middledoi
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide
Endocrine Related Cancer 2014cited by 127position: middledoi
The burden of influenza in England by age and clinical risk group: A statistical analysis to inform vaccine policy
Journal of Infection 2013cited by 256position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthew H. Kulke · Boston Medical Center2 papers (2014–2018)Pablo Lapuerta · BioTillion (United States)2 papers (2014–2018) · 1 papers (2015–2015)W. John Edmunds · London School of Hygiene & Tropical Medicine1 papers (2013–2013)Lowell Anthony · University of Kentucky1 papers (2018–2018)Petros Perros · Johannes Gutenberg University Mainz1 papers (2018–2018) · 1 papers (2018–2018)Thomas M. O’Dorisio · University of Iowa1 papers (2014–2014)Martine Valette · Hôpital de la Croix-Rousse1 papers (2015–2015) · 1 papers (2015–2015)Emily K. Bergsland · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2014–2014)Mark Jit · London School of Hygiene & Tropical Medicine1 papers (2013–2013)Brian Zambrowicz · Regeneron (United States)1 papers (2014–2014)Vincent Enouf · Centre National de la Recherche Scientifique1 papers (2015–2015)James C. Yao · The University of Texas MD Anderson Cancer Center1 papers (2014–2014)Maria Laura Silva · Université Claude Bernard Lyon 11 papers (2015–2015)Jessica Jackson · The University of Texas at Austin1 papers (2014–2014)Rocio García‐Carbonero · Research Institute Hospital 12 de Octubre1 papers (2018–2018)Phillip Banks · Icahn School of Medicine at Mount Sinai1 papers (2014–2014)Elizabeth Miller · Regeneron (United States)1 papers (2013–2013)